BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 29731479)

  • 21. Pilot clinical trial of 18F-fluorodeoxyglucose positron-emission mammography in the surgical management of breast cancer.
    Tafra L; Cheng Z; Uddo J; Lobrano MB; Stein W; Berg WA; Levine E; Weinberg IN; Narayanan D; Ross E; Beylin D; Yarnall S; Keen R; Sawyer K; Van Geffen J; Freimanis RL; Staab E; Adler LP; Lovelace J; Shen P; Stewart J; Dolinsky S
    Am J Surg; 2005 Oct; 190(4):628-32. PubMed ID: 16164937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG PET mammography device: initial experience.
    Rosen EL; Turkington TG; Soo MS; Baker JA; Coleman RE
    Radiology; 2005 Feb; 234(2):527-34. PubMed ID: 15671006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging.
    Schilling K; Narayanan D; Kalinyak JE; The J; Velasquez MV; Kahn S; Saady M; Mahal R; Chrystal L
    Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):23-36. PubMed ID: 20871992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast Cancer Detection Using a Low-Dose Positron Emission Digital Mammography System.
    Freitas V; Li X; Scaranelo A; Au F; Kulkarni S; Ghai S; Taeb S; Bubon O; Baldassi B; Komarov B; Parker S; Macsemchuk CA; Waterston M; Olsen KO; Reznik A
    Radiol Imaging Cancer; 2024 Mar; 6(2):e230020. PubMed ID: 38334470
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Watanabe G; Itoh M; Duan X; Watabe H; Mori N; Tada H; Suzuki A; Miyashita M; Ohuchi N; Ishida T
    Eur Radiol; 2018 May; 28(5):1929-1937. PubMed ID: 29218614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual time point FDG-PET/CT imaging... Potential tool for diagnosis of breast cancer.
    Zytoon AA; Murakami K; El-Kholy MR; El-Shorbagy E
    Clin Radiol; 2008 Nov; 63(11):1213-27. PubMed ID: 18929039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a Hanging-Breast PET System for Primary Tumor Visualization in Patients With Stage I-III Breast Cancer: Comparison With Standard PET/CT.
    Teixeira SC; Rebolleda JF; Koolen BB; Wesseling J; Jurado RS; Stokkel MP; Del Puig Cózar Santiago M; van der Noort V; Rutgers EJ; Valdés Olmos RA
    AJR Am J Roentgenol; 2016 Jun; 206(6):1307-14. PubMed ID: 27058014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of imaging sensitivity of positron emission mammography and whole-body PET in relation to tumor size.
    Yamamoto Y; Ozawa Y; Kubouchi K; Nakamura S; Nakajima Y; Inoue T
    Clin Nucl Med; 2015 Jan; 40(1):21-5. PubMed ID: 25423346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.
    Sheikhbahaei S; Trahan TJ; Xiao J; Taghipour M; Mena E; Connolly RM; Subramaniam RM
    Oncologist; 2016 Aug; 21(8):931-9. PubMed ID: 27401897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of incidental focal hypermetabolic uptake in the breast as detected by 18F-FDG PET/CT: clinical significance and differential diagnosis.
    Chae EY; Cha JH; Kim HH; Shin HJ; Kim HJ; Oh HY; Koh YH; Moon DH
    Acta Radiol; 2012 Jun; 53(5):530-5. PubMed ID: 22593124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers.
    Ulaner GA; Goldman DA; Gönen M; Pham H; Castillo R; Lyashchenko SK; Lewis JS; Dang C
    J Nucl Med; 2016 Sep; 57(9):1350-6. PubMed ID: 26940766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unexpected focal hypermetabolic activity in the breast: significance in patients undergoing 18F-FDG PET/CT.
    Korn RL; Yost AM; May CC; Kovalsky ER; Orth KM; Layton TA; Drumm D
    AJR Am J Roentgenol; 2006 Jul; 187(1):81-5. PubMed ID: 16794159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delineation of small mobile tumours with FDG-PET/CT in comparison to pathology in breast cancer patients.
    Hapdey S; Edet-Sanson A; Gouel P; Martin B; Modzelewski R; Baron M; Berghian A; Forestier-Lebreton F; Georgescu D; Picquenot JM; Gardin I; Dubray B; Vera P
    Radiother Oncol; 2014 Sep; 112(3):407-12. PubMed ID: 25216573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accuracy of 18F-FDG PET/CT for primary tumor visualization and staging in T1 breast cancer.
    Koolen BB; van der Leij F; Vogel WV; Rutgers EJ; Vrancken Peeters MJ; Elkhuizen PH; Valdés Olmos RA
    Acta Oncol; 2014 Jan; 53(1):50-7. PubMed ID: 23672678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating heterogeneity of primary tumor (18)F-FDG uptake in breast cancer with a dedicated breast PET (MAMMI): a feasibility study based on correlation with PET/CT.
    Koolen BB; Vidal-Sicart S; Benlloch Baviera JM; Valdés Olmos RA
    Nucl Med Commun; 2014 May; 35(5):446-52. PubMed ID: 24686195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can positron emission mammography help to identify clinically significant breast cancer in women with suspicious calcifications on mammography?
    Bitencourt AG; Lima EN; Macedo BR; Conrado JL; Marques EF; Chojniak R
    Eur Radiol; 2017 May; 27(5):1893-1900. PubMed ID: 27585658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initial experience of integrated PET/MR mammography in patients with invasive ductal carcinoma.
    Kong EJ; Chun KA; Bom HS; Lee J; Lee SJ; Cho IH
    Hell J Nucl Med; 2014; 17(3):171-6. PubMed ID: 25397622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An amorphous selenium based positron emission mammography camera with avalanche gain.
    Reznik A; Lui BJ; Rowlands JA
    Technol Cancer Res Treat; 2005 Feb; 4(1):61-7. PubMed ID: 15649089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Performance of 18F-FDG PET/CT in the detection of primary breast cancer and staging of the regional lymph nodes].
    Zhao TT; Li JG; Li YM
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):206-9. PubMed ID: 17649638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positron emission mammography in the diagnosis of breast cancer. Is maximum PEM uptake value a valuable threshold for malignant breast cancer detection?
    Müller FH; Farahati J; Müller AG; Gillman E; Hentschel M
    Nuklearmedizin; 2016; 55(1):15-20. PubMed ID: 26627876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.